Torray Fund Marsh & McLennan Companies, Inc transactions over time
MRSH
Marsh & McLennan Companies, Inc historical holders
total: 9
Transactions details
- Total transactions:
- 11
- New positions:
- 1
- Added:
- 2
- Reduced:
- 8
- Held since:
- 2020 Q1
- Held for:
- 27 quarters
- Latest activity:
- 2026 Q3
Torray Fund has been an institutional investor in Marsh & McLennan Companies, Inc (MRSH) since 2020 Q1. According to 2026 Q3 report, Torray Fund holds 48,454 shares with a market value of roughly $9.20M representing 2.41% of their equity portfolio. The fund/company first acquired MRSH in 2020 Q1, initially purchasing 156,818 shares. Since the initial investment, Torray Fund has made 10 more transactions in this position.
Does Torray Fund still hold MRSH?
Yes, Torray Fund continues to hold Marsh & McLennan Companies, Inc (MRSH). According to their 2026 Q3 report, they maintain a position of 48,454 shares valued at approximately $9.20M, representing 2.41% of their equity portfolio.
When did Torray Fund first invest in MRSH?
Torray Fund first invested in Marsh & McLennan Companies, Inc (MRSH) in 2020 Q1 at the reported quarter-end price of $86.46 per share, acquiring 156,818 shares in their initial purchase.
What is Torray Fund's average cost basis for MRSH?
Based on historical transaction data, Torray Fund's estimated cost basis for Marsh & McLennan Companies, Inc (MRSH) is approximately $92.22 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $92.22
- Weighted AVG sell price:
- $169.67
MRSH transactions history by Torray Fund
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
2.41%
|
48,454
|
$189.80
|
$9,196,569
|
-35.39% (-26,546)
|
-1.42%
|
|
2026 Q2
|
3.38%
|
75,000
|
$159.97
|
$11,997,750
|
+7.14% (+5,000)
|
+0.23%
|
|
2026 Q1
|
3.83%
|
70,000
|
$186.74
|
$13,071,800
|
-6.67% (-5,000)
|
-0.26%
|
|
2025 Q4
|
3.85%
|
75,000
|
$183.45
|
$13,758,750
|
+8.99% (+6,185)
|
+0.32%
|
|
2025 Q2
|
4.85%
|
68,815
|
$233.66
|
$16,079,313
|
-9.23% (-6,996)
|
-0.47%
|
|
2024 Q3
|
4.86%
|
75,811
|
$227.51
|
$17,247,761
|
-10.76% (-9,145)
|
-0.61%
|
|
2022 Q4
|
4.36%
|
84,956
|
$165.48
|
$14,058,519
|
-10.31% (-9,761)
|
-0.57%
|
|
2021 Q4
|
4.36%
|
94,717
|
$173.82
|
$16,463,709
|
-18.04% (-20,842)
|
-0.98%
|
|
2021 Q2
|
4.08%
|
115,559
|
$140.68
|
$16,256,840
|
-16.25% (-22,415)
|
-0.81%
|
|
2020 Q4
|
4.53%
|
$117.00
|
-12.02% (-18,844)
|
|||
|
2020 Q1
|
4.59%
|
$86.46
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.